India saw a single day rise of 112 cases of COVID-19, while the number of active cases of the infection was recorded at 1,460, the health ministry said on Monday. No deaths have been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, but cases had begun to increase after emergence of a new variant and cold weather conditions. After December 5, the maximum single-day rise of 841 new cases was reported on December 31, which is 0.2 per cent of the peak cases reported in May 2021, sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," the source stated. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily new c
India saw a single day rise of 182 new cases of COVID-19, while the number of active cases of the infection has declined to 1,525, the health ministry said on Sunday. One death has been reported from Kerala in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, but cases began to increase after emergence of a new variant and cold weather conditions. After December 5, a maximum of a single-day rise of 841 new cases were reported on December 31, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, around 92 per cent are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," the official source stated. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily
India has registered a single-day rise of 159 new COVID-19 infections and the count of active cases of the disease stands at 1,623 in the country, the Union health ministry said on Saturday. One fatality due to the infection was reported in Kerala in a span of 24 hours, according to the data updated by the ministry at 8 am. The number of daily cases of COVID-19 in the country had dropped to double-digits by December 5, but it began to climb after the emergence of a new variant and the cold weather conditions. After December 5, the highest single-day rise of 841 new cases was reported on December 31. Of the total active cases, around 92 per cent are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," an official source said. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily new cases and death
India saw a single-day rise of 187 coronavirus cases, while the number of active infections was recorded at 1,674, the health ministry said on Friday. One new death from Maharashtra has been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double digits till December 5, but cases began to increase after emergence of a new variant and cold weather conditions. After December 5, the highest single-day rise of 841 new cases was reported on December 31, 2023, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," an official source stated. India has witnessed three waves of COVID-19 in the past with the p
AIIMS-Delhi and the Indian Council of Medical Research have started a multi-centre trial to evaluate three indigenous human papillomavirus tests for detecting cervical cancer so that they meet international quality standards, a senior doctor said on Thursday. The trial began on January 22 and aims to develop an accurate and affordable test which can be integrated into the National Cancer Screening Programme, Dr Neerja Bhatla, Head of Department of Obstetrics and Gynaecology at AIIMS said. "The present indigenous tests available have not yet been validated for conformity with international standards," she said. The Visual Inspection with Acetic Acid (VIA) test for cancer detection which has a risk of false positive is being used under the national programme currently and it is not accurate, Bhatla said. To validate these tests, the Biotechnology Industry Research Assistance Council (BIRAC) has collaborated with WHO's International Agency for Research on Cancer (IARC). The agency wou
A total of 1,640 cases of COVID-19 sub-variant JN.1 have been detected in the country so far, with Madhya Pradesh becoming the latest state to record its presence, INSACOG said on Tuesday. Data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed Maharashtra has recorded the highest number of JN.1 cases at 477 followed by Karnataka at 249. Andhra Pradesh recorded 219 JN.1 cases while Kerala registered 156 cases of the variant and Gujarat recorded 127 such cases.West Bengal recorded 96 JN.1 cases, Goa 90 and Tamil Nadu 89. Rajasthan has recorded 38 JN.1 cases, Telangana 32, Chhattisgarh 25, Delhi 21, Uttar Pradesh nine, Haryana five, Odisha three, and Uttarakhand, Manipur, Madhya Pradesh and Nagaland one each, according to the data accessed by PTI. The highest number of cases were recorded in December at 1,291 while in January 315 JN.1 cases were detected and 34 sub-variant cases were detected in November. Last month, the Centre has asked the states and Union ...
India reported a single-day rise of 203 Covid cases while the active caseload was recorded at 2,034, the Union Health Ministry said on Monday. Two deaths -- one each in Kerala and Maharashtra -- have been reported in 24 hours, according to the data updated at 8 am. The number of daily cases had dropped to double-digits till December 5 but began to rise after the emergence of a new variant and cold conditions. A single-day rise of 841 fresh infections -- 0.2 per cent of the peak cases reported in May 2021 -- were recorded on December 31, official sources have said. Of the total active cases, a large majority of around 92 per cent are recovering in home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in new cases nor a surge in hospitalisation and mortality," the official sources have said. India has witnessed three COVID-19 waves with the peak incidence of daily new cases and deaths being reported during the Delta w
India saw a single-day rise of 313 new Covid cases, while the active caseload has declined to 2,041, the health ministry said on Saturday. Three deaths -- two from Karnataka and one from Maharashtra -- were reported in the last 24 hours, according to data updated by the ministry at 8 am. The number of active Covid cases in the country stood at 2,331 on Friday, according to the ministry's website. The number of daily cases of Covid had dropped to double digits till December 5, but it began to rise after the emergence of a new variant and cold weather conditions. After December 5, the highest single-day rise of 841 new cases was reported on December 31, 2023, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge
India saw a single day rise of 305 new cases of COVID-19, while the number of active cases of the infection has declined to 2,439, the health ministry said on Thursday. Three deaths -- one each from Maharashtra, Karnataka and Gujarat -- have been reported in a span of last 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, but cases began to increase after emergence of a new variant and cold weather conditions. After December 5, a maximum of a single-day rise of 841 new cases were reported on December 31, which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, around 92 per cent are recovering under home isolation. "The currently available data suggests that the JN.1 sub-variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," the official source stated. India has witnessed three waves
Redseer expects the market to grow at 14% CAGR to reach $60bn size by 2027 from $31 bn in 2022
In the backdrop of a caution by the Indian Pharmacopoeia Commission (IPC) against mefenamic acid, a major component of painkiller meftal, the medicine's manufacturer on Tuesday said the alert seeks to advise doctors and patients to monitor the possibility of an adverse reaction of the drug. "The alert issued by IPC was to advise doctors and patients to monitor the possibility of an adverse drug reaction of mefenamic acid, which does not in any way impact the safety, efficacy and high quality of the brands that are established and supported by clinical studies," Blue Cross Laboratories, which makes meftal and meftal-spas, said in a statement. The IPC on November 30 had issued an alert on mefenamic acid stating that a preliminary analysis of adverse drug reactions from the Pharmacovigilance Programme of India (PvPI) database revealed drug reactions with eosinophilia and systemic symptoms (DRESS) syndrome. "Healthcare professionals, patients/consumers are advised to closely monitor th
The annual number of deaths from fungal disease worldwide has risen to 3.75 million, double the previous estimate, according to a study using data from over 80 countries, including India. The research, published in the journal Lancet Infectious Diseases, calculated an annual total at about 6.55 million acute cases. The updated mortality figures of fungal disease dwarf deaths from other single pathogens, killing six times more people than malaria, and almost 3 times as many than tuberculosis, the researchers said. The work is the result of a collaboration of over 300 professionals across the world who contributed to published estimates for their country and individual fungal diseases. Previous estimates were imprecise as many fungal disease exacerbate an existing disorder, itself often severe, such as leukaemia or AIDS, said David Denning, a professor of infectious disease at The University of Manchester, UK. However according to the study, of the deaths linked to fungal disease, .
Experts anticipate indigenous vaccine to help curb cases, health ministry yet to take a decision on roll-out
India has recorded 272 fresh cases of Covid, while the number of active cases of the infection has declined to 2,990, the health ministry said on Monday. No deaths have been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, 2023 but they began to increase after emergence of a new variant and cold weather conditions. A single day rise of 841 new cases were reported on December 31, 2023 which is 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in new cases nor a surge in hospitalisation and mortality," the sources stated. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily new cases and deaths being reporte
Uttar Pradesh topped the list of states with the highest number of Ayushman cards at 48.3 million cards. It was followed by Madhya Pradesh at 37.8 million cards and Maharashtra at 23.9 million cards
India has recorded 441 fresh COVID-19 infections while the number of active cases has come down to 3,238, the Union health ministry said on Saturday. No deaths were reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases was in double digits till December 5 but it began to rise again amid cold weather conditions and after the emergence of a new COVID-19 variant, JN.1. After December 5, the highest single-day rise of 841 cases was reported on December 31, 2023, which was 0.2 per cent of the peak cases reported in May 2021. Of the 3,238 active cases, a large majority (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in the new cases nor a surge in the hospitalisation and mortality," an official source said. India has witnessed three waves of COVID-19 in the past with the peak incidence of daily cases and deaths being repo
The number of cases of COVID-19 sub-variant JN.1 has crossed 1,000 mark with Uttar Pradesh becoming the latest state to join the list of 16 states and UTs which have detected its presence, according to INSACOG. The data compiled by the Indian SARS-CoV-2 Genomics Consortium (INSACOG) showed Karnataka has reported the highest number of cases at 214, followed by Maharashtra (170), Kerala (154), Andhra Pradesh (189), Gujarat (76) and Goa (66). Telangana and Rajasthan have recorded 32 JN.1 cases each, Chhattisgarh has recorded 25, Tamil Nadu 22, Delhi 16, Uttar Pradesh 6, Haryana five, Odisha three, West Bengal two and Uttarakhand one, according to the data. A total of 1,013 cases of JN.1 have been detected till now across the 16 states and UTs. The Centre has asked the states and Union territories to maintain a constant vigil amid an uptick in the number of Covid cases and the detection of the JN.1 sub-variant in the country. The states have been urged to ensure effective compliance o
India has recorded 609 new cases of Covid, while the number of active cases of the infection has declined to 3,368, the health ministry said on Friday. Three deaths -- two in Kerala and one in Karnataka -- have been reported in a span of 24 hours, according to the ministry's data updated at 8 am. The number of daily cases had dropped to double-digits till December 5, 2023 but cases began to increase after emergence of a new variant and cold weather conditions. After December 5, 841 new cases were reported on December 31, 2023 which was 0.2 per cent of the peak cases reported in May 2021, official sources said. Of the total active cases, a large majority of these (around 92 per cent) are recovering under home isolation. "The currently available data suggests that the JN.1 variant is neither leading to an exponential rise in new cases nor a surge in hospitalisation and mortality," the official source stated. India has witnessed three waves of COVID-19 in the past with the peak inci
Akumentis Healthcare on Wednesday said it has introduced a drug for the treatment of epilepsy. The Mumbai-based company has launched Clasepi, a DCGI-approved prescription cannabidiol (CBD) specifically formulated to address seizures linked with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome, or Tuberous Sclerosis Complex (TSC) in patients aged 1 year and older, it said in a statement. Clinical studies have demonstrated Clasepi's efficacy in reducing seizures, especially in cases where conventional anti-seizure medications have proven ineffective, it added. "We understand the immense physical and emotional toll that frequent seizures can have on patients and their families," Akumentis Executive Director Kanishk Jain said. This is the driving force behind our commitment to developing novel solutions that effectively relieves the complexities of these disorders, he added. According to the World Health Organisation (WHO), epilepsy constitutes a considerable portion of the global disea
The health department of the Delhi government has issued a show-cause notice to the Guru Teg Bahadur (GTB) hospital authorities asking to "terminate" the services of a senior resident doctor, days after the death of an injured man, who was allegedly denied admission at four different hospitals. Pramod, 47, who was arrested after a 21-year-old woman alleged that he had molested her in an inebriated state, died of the injuries he suffered after jumping out of a moving police van on January 3, a senior officer said. He was allegedly denied admission by four government hospitals, including three Delhi government-run facilities, due to the unavailability of beds or equipment, a senior officer had said earlier. The show-cause notice issued recently mentions news reports on the alleged incident published on January 4. The notice said "the entire episode shows lack of empathy and professionalism among the medical officers ... as well as lack of supervision on the part of the concerned medi